Kyong Ran Peck

16.4k citations
443 papers · 10.0k indexed · h-index 51

Kyong Ran Peck

428 papers receiving 9.8k citations

Peers

Kyong Ran Peck
Comparison fields: 5 of 174
  • Molecular Medicine 3.2k
  • Applied Microbiology and Biotechnology 1.1k
  • Endocrinology 1.3k
  • Clinical Biochemistry 1.5k
  • Infectious Diseases 3.6k
Replace Doo Ryeon Chung with:
Doo Ryeon Chung South Korea
Deirdre L. Church Canada
Francesc Marco Spain
Cheol‐In Kang South Korea
Mario Venditti Italy
Winfried V. Kern Germany
Mario Tumbarello Italy
Hilmar Wisplinghoff Germany
Shan‐Chwen Chang Taiwan
Lisa Saiman United States
Kyong Ran Peck relative to Doo Ryeon Chung South Korea Doo Ryeon Chung's profile →
Citations per field
00.5×1.5×
Doo Ryeon Chung · 1×
Citations per year

Countries citing papers authored by Kyong Ran Peck

Since Specialization
Citations

This map shows the geographic impact of Kyong Ran Peck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyong Ran Peck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyong Ran Peck more than expected).

Fields of papers citing papers by Kyong Ran Peck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyong Ran Peck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyong Ran Peck. The network helps show where Kyong Ran Peck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kyong Ran Peck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kyong Ran Peck Line = papers co-authored together Kyong Ran Peck links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20250
4 20242
5 20241
6 20231
7 20234
8 20234
9 20231
10 20232
11 20233
12 20235
13 20220
14 20214
15 20213
16 20216
17 202027
18 202011
19 201168
20 200734

About Kyong Ran Peck

Kyong Ran Peck is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 443 papers that have together received 10.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (111 papers), Antimicrobial Resistance in Staphylococcus (81 papers), Bacterial Identification and Susceptibility Testing (79 papers), Antibiotics Pharmacokinetics and Efficacy (50 papers), Pneumonia and Respiratory Infections (49 papers), SARS-CoV-2 and COVID-19 Research (47 papers), COVID-19 Clinical Research Studies (40 papers) and Urinary Tract Infections Management (37 papers). The work is most often cited by research in Molecular Medicine (3.2k citations), Applied Microbiology and Biotechnology (1.1k citations) and Endocrinology (1.3k citations). Kyong Ran Peck has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Doo Ryeon Chung, Cheol‐In Kang, Kwan Soo Ko, Jae‐Hoon Song, Nam Yong Lee, Jae‐Hoon Song, Kim Ys, Young Eun Ha, Won Sup Oh and Yu Mi Wi. Their work appears in journals such as JAMA, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026